phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

New Treatment Combination Delays Multiple Myeloma Progression and May Improve Survival, Study Finds

Patients with relapsed multiple myeloma lived significantly longer without disease progression and showed early survival gains in a global phase 3 trial of a talquetamab-based immunotherapy combo, offering new hope for improved treatment outcomes.

June 15, 2026


June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026

June 16 2026

June 15 2026

June 14 2026

June 13 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy